OMNICELL,INC. (NASDAQ:OMCL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 5, 2019, at a meeting of the Compensation Committee (the “Committee”) of the Board of Directors of Omnicell,Inc. (the “Company”), the Committee adopted a policy that amends the form of Option Agreement (the “Amendment”) that is attached to the form of Option Grant Notice (the “Option Grant Notice”) for the Company’s 2009 Equity Incentive Plan, as amended (the “Plan”). The Amendment extends the post-termination exercise period of nonstatutory stock options granted to the Plan for certain employees of the Company or a subsidiary of the Company who have attained age 55 and who have provided ten or more Years of Continuous Service (as defined in the Amendment) to the Company (the “Eligible Employees”). The post-termination exercise period for a stock option held by an Eligible Employee was extended to the expiration of the term of such stock option (the “Extended Exercise Period”). to the Plan, the vesting of an Eligible Employee’s stock options (and other equity awards) will cease on the date of his or her departure from the Company, and no additional vesting will occur during the Extended Exercise Period.
References to the terms of the Amendment are qualified in their entirety by reference to the full text of the Option Grant Notice, which is incorporated herein by reference to Exhibit 10.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
OMNICELL, Inc Exhibit
EX-10.1 2 exhibit101-omcl8koptionag.htm EXHIBIT 10.1 Exhibit Exhibit 10.1OptionOmnicell,…
To view the full exhibit click here
About OMNICELL,INC. (NASDAQ:OMCL)
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.
